Hitachi Medical warns of first-half loss

Article

Hitachi Medical expects to report a net loss of $5.67 million for the half-year ended Sept. 30. The company said that despite strong U.S. sales of MRI and diagnostic ultrasound systems, CT and ultrasound sales in Japan have been weak. Hitachi had

Hitachi Medical expects to report a net loss of $5.67 million for the half-year ended Sept. 30. The company said that despite strong U.S. sales of MRI and diagnostic ultrasound systems, CT and ultrasound sales in Japan have been weak.

Hitachi had projected a profit of $3.02 million for the period. The firm said group sales would likely reach $451 million, some $54.44 million short of the original projection.

A spokesperson for the Hitachi Medical Corporation of America said the ultrasound division in the U.S. had exceeded its sales goals in the past few months. She said the company plans new product introductions at the RSNA show.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.